ArticlemedRxiv : the preprint server for health sciences2025
Point-of-Care Ultrasound as a Prognostic Tool in Critically Ill Patients: Insights Beyond Core Muscle Mass.
Article in medRxiv : the preprint server for health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Updated by
Authors and funding
5 authors.
Funding
Abstract
Background: Muscle wasting is a major concern in ICUs, contributing to morbidity, mortality, and prolonged rehabilitation. While CT-derived L3 Skeletal Muscle Index (L3SMI) assesses core muscle mass, it may not capture peripheral muscle atrophy or fluid-based changes. Point-of-care ultrasound (POCUS) offers a rapid, non-invasive alternative. This study evaluated the prognostic value of POCUS-based muscle measurements compared with L3SMI in predicting mortality, frailty, and functional outcomes. Methods: In this prospective study, 50 critically ill adults meeting Sepsis-3 criteria or requiring respiratory/vasopressor support underwent POCUS assessments of biceps brachii, rectus femoris, and vastus intermedius thickness at days 1, 7, and 14 post-ICU admission. Twenty-eight patients also had CT scans within seven days for L3SMI calculation. The primary outcome was 90-day mortality; secondary outcomes included in-hospital and 30-day mortality, Clinical Frailty Score, and Zubrod/ECOG performance status. Muscle measurements were analyzed both raw and indexed to body surface area, with predictive performance assessed via correlation and ROC analysis. Results: Day 1 biceps brachii thickness strongly predicted in-hospital mortality (AUC 0.84; sensitivity 1.0, specificity 0.67) and retained predictive value for 30-day and 90-day mortality. Vastus intermedius thickness on day 1 was moderately predictive (AUC 0.79). At later time points, larger vastus intermedius measurements correlated negatively with ICU- and ventilator-free days, suggesting edema-related pseudohypertrophy. L3SMI did not significantly correlate with ultrasound-based muscle measurements or clinical outcomes. POCUS-derived peripheral muscle indexing was associated with frailty indices, highlighting its role in capturing meaningful functional deficits. Conclusion: POCUS-based muscle assessments, particularly of the biceps brachii and vastus intermedius, provide valuable prognostic insights beyond conventional L3SMI. While L3SMI remains a core muscle measure, fluid shifts and localized muscle wasting in critical illness may be better captured by ultrasound.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.